HealthDay – WEDNESDAY, Feb. 24 (HealthDay News) — Mirapex ER (pramipexole dihydrochloride extended-release) has been approved by the U.S. Food and Drug Administration as a once-daily option to treat early Parkinson’s disease, drug maker Boehringer Ingelheim said in a news release. Good Ideas. Self help e-books and courses. Good Ideas. [...]

This entry was posted on Sunday, February 28th, 2010 at 3:23 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.